Fragment-to-Lead Medicinal Chemistry Publications in 2018
- 14 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (9), 4430-4444
- https://doi.org/10.1021/acs.jmedchem.9b01581
Abstract
This Perspective, the fourth in an annual series, summarizes fragment-to-lead (F2L) success stories published during 2018. Topics such as target class, screening methods, physicochemical properties, and ligand efficiency are discussed for the 2018 examples as well as for the combined 111 F2L examples covering 2015-2018. While the overall properties of fragments and leads have remained constant, a number of new trends are noted, for example, broadening of target class coverage and application of FBDD to covalent inhibitors. Moreover, several studies make use of fragment hits that were previously described in the literature, illustrating that fragments are versatile starting points that can be optimized to structurally diverse leads. By focusing on success stories, the hope is that this Perspective will identify and inform best practices in fragment-based drug discovery.This publication has 66 references indexed in Scilit:
- Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)Journal of Medicinal Chemistry, 2018
- Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth ApproachJournal of Medicinal Chemistry, 2018
- Fragment-to-Lead Medicinal Chemistry Publications in 2017Journal of Medicinal Chemistry, 2018
- Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibitionBioorganic & Medicinal Chemistry, 2018
- Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug DesignJournal of Medicinal Chemistry, 2018
- Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug DesignJournal of Medicinal Chemistry, 2018
- Fragment-to-Lead Medicinal Chemistry Publications in 2016Journal of Medicinal Chemistry, 2017
- Fragment-to-Lead Medicinal Chemistry Publications in 2015Journal of Medicinal Chemistry, 2016
- Twenty years on: the impact of fragments on drug discoveryNature Reviews Drug Discovery, 2016
- The rise of fragment-based drug discoveryNature Chemistry, 2009